Medicine and Dentistry
Acute Coronary Syndrome
79%
Percutaneous Aortic Valve Replacement
79%
Revascularization
67%
Rapamycin
65%
Percutaneous Coronary Intervention
64%
Cardiovascular System
46%
Target Lesion
43%
Malignant Neoplasm
40%
Acute Heart Infarction
37%
Cohort Analysis
37%
Heart Failure
34%
Myocardial Infarction
32%
Aortic Valve
31%
Cardiovascular Disease
31%
All Cause Mortality
30%
Target Lesion Revascularization
29%
Aortic Stenosis
25%
Coronary Angiography
24%
Coronary Artery Disease
24%
Combination Therapy
23%
Aortic Valve Stenosis
23%
Heart Death
21%
ST Segment Elevation Myocardial Infarction
21%
Patient Characteristics
19%
Cardiovascular Risk
18%
Bleeding
18%
Randomized Clinical Trial
18%
Cost-Effectiveness Analysis
18%
Myocarditis
17%
Umirolimus
17%
Computer Assisted Tomography
17%
Odds Ratio
17%
Diabetes
15%
Monomorphic Ventricular Tachycardia
15%
Vein Graft
15%
Heart Left Ventricle Ejection Fraction
15%
Coronary Artery
15%
Primary Percutaneous Coronary Intervention
15%
Heart Ventricle Arrhythmia
15%
Out of Hospital Cardiac Arrest
15%
Intervention Trial
15%
Conditioning
15%
Emergency Department
15%
Coronary Computed Tomography Angiography
15%
Randomized Controlled Trial
15%
Aortic Valve Replacement
15%
Ethnic Disparity
15%
Chronic Total Occlusion
15%
Diabetes Mellitus
15%
Psychiatric Diagnosis
15%
Keyphrases
Clinical Outcome
68%
Percutaneous Coronary Intervention
65%
Orsiro Stent
51%
Acute Coronary Syndrome
47%
Transcatheter Aortic Valve Implantation
47%
Stent
42%
Sirolimus
35%
Target Lesion Failure
35%
Ultra-thin Strut
33%
Bleeding Risk
31%
Revascularization
31%
Anti-CD34 Antibody
31%
Dual Therapy
31%
Target Lesion Revascularization
31%
Rate Ratio
30%
Randomized Trial
24%
All-comers
23%
Biodegradable Polymer Drug-eluting Stents
21%
High Bleeding Risk
20%
Registry-based
20%
Biolimus
19%
Scandinavian
19%
Heart Failure
19%
Myocardial Infarction
18%
Cardiac Death
17%
Nationwide Registry
17%
Ischemic Risk
17%
All-cause Mortality
17%
Biodegradable Polymers
17%
Confidence Interval
16%
Patients with Cancer
15%
Dental Screening
15%
Sirolimus-eluting Stent
15%
Biodegradable Polymer Biolimus-eluting Stents
15%
MINOCA
15%
Randomized Clinical
15%
Cause of Death
15%
Cancer Site
15%
Single Center
15%
Ventricular Arrhythmia
15%
Cardiovascular Mortality
15%
Cardiovascular Intervention
15%
Disease-specific
15%
Polymer-free
15%
Biodegradable Polymer Sirolimus-eluting Stent
15%
Acute Myocarditis
15%
Clinical Comparison
15%
Hospital Prevalence
15%
ST-elevation Myocardial Infarction (STEMI)
15%
Coated Stent
15%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Coronary Syndrome
100%
Rapamycin
97%
Heart Infarction
67%
CD34 Antibody
63%
Bleeding
47%
Heart Death
43%
All Cause Mortality
40%
Malignant Neoplasm
35%
Comorbidity
33%
Umirolimus
33%
Acute Heart Infarction
31%
Stent Thrombosis
29%
Randomized Clinical Trial
23%
Cohort Study
23%
Clopidogrel
20%
Anemia
19%
Major Adverse Cardiac Event
19%
Prasugrel
18%
Ticagrelor
18%
Coronary Artery Disease
15%
Diabetes Mellitus
15%
Observational Study
15%
Fluorouracil
15%
Disease
15%
Heart Ventricle Arrhythmia
15%
Myocarditis
15%
Antithrombocytic Agent
15%
ST Segment Elevation Myocardial Infarction
15%
Prevalence
15%
Cardiovascular Mortality
15%
Digestive System Cancer
15%
Stable Angina Pectoris
15%
Chronic Total Occlusion
15%
Bacterial Endocarditis
15%
Heart Failure
14%
Mortality Rate
13%
Pharmacotherapy
11%
Infarction
10%
Antiplatelet
9%
Noninferiority Trial
9%
Cardiovascular Disease
8%
Efficacy Study
7%
Ischemic Heart Disease
6%
Heart Ventricle Fibrillation
5%
